These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28353026)

  • 1. Effect of Milrinone Infusion on Pulmonary Vasculature and Stroke Work Indices: A Single-Center Retrospective Analysis in 69 Patients Awaiting Cardiac Transplantation.
    Abramov D; Haglund NA; Di Salvo TG
    Am J Cardiovasc Drugs; 2017 Aug; 17(4):335-342. PubMed ID: 28353026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
    Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS
    J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term intravenous sodium nitrite infusion improves cardiac and pulmonary hemodynamics in heart failure patients.
    Ormerod JO; Arif S; Mukadam M; Evans JD; Beadle R; Fernandez BO; Bonser RS; Feelisch M; Madhani M; Frenneaux MP
    Circ Heart Fail; 2015 May; 8(3):565-71. PubMed ID: 25838311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
    Botha P; Parry G; Dark JH; Macgowan GA
    J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Effect of Levosimendan and Milrinone in Cardiac Surgery Patients With Pulmonary Hypertension and Left Ventricular Dysfunction.
    Mishra A; Kumar B; Dutta V; Arya VK; Mishra AK
    J Cardiothorac Vasc Anesth; 2016 Jun; 30(3):639-46. PubMed ID: 27321790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intravenous milrinone followed by titration of high-dose oral vasodilator therapy on clinical outcome and rehospitalization rates in patients with severe heart failure.
    Cusick DA; Pfeifer PB; Quigg RJ
    Am J Cardiol; 1998 Nov; 82(9):1060-5. PubMed ID: 9817482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
    Kieler-Jensen N; Lundin S; Ricksten SE
    J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can echocardiographic evaluation of cardiopulmonary hemodynamics decrease right heart catheterizations in end-stage heart failure patients awaiting transplantation?
    Kuppahally SS; Michaels AD; Tandar A; Gilbert EM; Litwin SE; Bader FM
    Am J Cardiol; 2010 Dec; 106(11):1657-62. PubMed ID: 21094370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective pulmonary vasodilation with inhaled aerosolized milrinone in heart transplant candidates.
    Sablotzki A; Starzmann W; Scheubel R; Grond S; Czeslick EG
    Can J Anaesth; 2005 Dec; 52(10):1076-82. PubMed ID: 16326679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study.
    Barton P; Garcia J; Kouatli A; Kitchen L; Zorka A; Lindsay C; Lawless S; Giroir B
    Chest; 1996 May; 109(5):1302-12. PubMed ID: 8625683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular assist device support of medically unresponsive pulmonary hypertension and aortic insufficiency.
    Adamson RM; Dembitsky WP; Jaski BE; Daily PO; Moreno R; Kim JC; Sono J; Akasaka T; Hoagland PM; Gordon JB
    ASAIO J; 1997; 43(4):365-9. PubMed ID: 9242955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique.
    Ludmer PL; Wright RF; Arnold JM; Ganz P; Braunwald E; Colucci WS
    Circulation; 1986 Jan; 73(1):130-7. PubMed ID: 3940664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic effects of an acute vasodilator challenge in heart failure patients with reduced ejection fraction and different forms of post-capillary pulmonary hypertension.
    Ghio S; Crimi G; Temporelli PL; Traversi E; La Rovere MT; Cannito A; Vizza D; Scelsi L; Raineri C; Guazzi M; Oltrona Visconti L
    Eur J Heart Fail; 2018 Apr; 20(4):725-734. PubMed ID: 29148140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of milrinone in pre-transplant assessment of patients with congestive heart failure and pulmonary hypertension.
    Pamboukian SV; Carere RG; Webb JG; Cook RC; D'yachkova Y; Abel JG; Ignaszewski AP
    J Heart Lung Transplant; 1999 Apr; 18(4):367-71. PubMed ID: 10226902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic effects of milrinone with and without a bolus loading infusion.
    Baruch L; Patacsil P; Hameed A; Pina I; Loh E
    Am Heart J; 2001 Feb; 141(2):266-73. PubMed ID: 11174341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of continuous-flow ventricular assist device therapy with intensive medical therapy in fixed pulmonary hypertension secondary to advanced left heart failure.
    Kumarasinghe G; Jain P; Jabbour A; Lai J; Keogh AM; Kotlyar E; Jansz P; Macdonald PS; Hayward CS
    ESC Heart Fail; 2018 Aug; 5(4):695-702. PubMed ID: 29573567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Canadian multicentre study of a 48 h infusion of milrinone in patients with severe heart failure.
    Pflugfelder PW; O'Neill BJ; Ogilvie RI; Beanlands DS; Tanser PH; Tihal H; Mizgala HF; Fitchett DH; Kostuk WJ
    Can J Cardiol; 1991; 7(1):5-10. PubMed ID: 2025794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dobutamine and Nitroglycerin Versus Milrinone for Perioperative Management of Pulmonary Hypertension in Mitral Valve Surgery. A Randomized Controlled Study.
    Eskandr AM; Metwally AA; Abu Elkassem MS; Sadik SA; Elmiligy AE; Mourad M; Hussein L
    J Cardiothorac Vasc Anesth; 2018 Dec; 32(6):2540-2546. PubMed ID: 29880427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of milrinone and epinephrine or dopamine on biventricular function and hemodynamics in an animal model with right ventricular failure after pulmonary artery banding.
    Hyldebrandt JA; Sivén E; Agger P; Frederiksen CA; Heiberg J; Wemmelund KB; Ravn HB
    Am J Physiol Heart Circ Physiol; 2015 Jul; 309(1):H206-12. PubMed ID: 25957222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.